{"summary": "in 2016, 249,260 new breast cancer cases and 40,890 breast cancer deaths are projected to occur in the united states. terpenoids are the largest group of natural compounds found in plants. terpenoids regulate tumor cell proliferation, transformation, survival, invasion, angiogenesis, metastasis, chemoresistance and radioresistance. some studies have shown that the addition of lipophilic fragments to antitumor molecules could increase their anticancer activity [22,23,24,25] in addition, natural products which were conjugated with amino acids provide improved bioacitivity [26,27,28]. in total, forty derivatives of GA were successfully synthesized. the synthesis of new GA derivatives 17\u201356 was carried out according to the steps shown in Scheme 1. Scheme 1. Preparation of glycyrrhetinic acid derivatives 17\u201356. all these derivatives are new compounds which were not previously reported. d from 1.88 0.20 to 24.45 1.36 M on MCF-7 cells and from 1.37 0.18 to 23.15 1.07 M on MDA-MB-231 cells. compound 42 showed the highest cytotoxicity with the lowest IC50 values of 1.88 0.20 M on MCF-7 cells and 1.37 0.18 M on MDA-MB-231 cells. 0.55 21 8.54 0.67 7.31 0.16 18.59 0.54 50 5.12 0.58 3.13 0.45 9.79 0.37 22 19.27 1.01 9.41 1.03 21.11 0.73 51 8.81 0.20 4.67 0.74 12.52 0.40 23 14.90 0.75 20.84 1.20 24.09 0.88 52 6.93 0.63 3.27 0.66 10.06 0.28 24 19.30 0.98 23.15 1.07 22.88 0.68 53 7.20 0.55 3.54 0.46 8.49 0.51 41 6 the lipophilic fragments with a methoxy group have higher anticancer activity. the introduction of l-selenomethionine leads to lower IC50 values than l-methionine (compounds 42, 44, 46, 48, 50, 52, 54, and 56) compound 42 showed the highest cytotoxicity with the lowest IC50 values of 1.88 0.20 to 24.45 1.36 M on MCF-7 cells. compound 42 showed the highest cytotoxicity with the lowest IC50 values of 1.88 0.20 M on MCF-7 cells and 1.37 0.18 M on MDA-MB-231 cells. 70 1.73 63.41 1.07 45 7.24 0.30 6.43 0.84 8.48 0.73 17 13.640.93 5.03 0.82 17.32 1.21 46 6.02 0.35 6.27 0.24 6.33 0.19 18 22.46 1.26 8.14 0.76 22.80 0.97 47 2.65 0.12 2.31 0.65 5.65 1.02 19 20.29 1.47 14.38 0.52 29.63 1.16 48 2.42 0.23 1.86 0.29 7.08 0.73 20 24.45 1.36 14.46 0. a IC50 is the drug concentration effective in inhibiting 50% of the cell growth measured by MTT method. doxorubicin (ADR) was used as positive control in this study. lipophilic fragments with a methoxy group have higher anticancer activity. 1H-NMR and 13C-NMR spectra were recorded on a Bruker-400 instrument (Bruker, Billerica, MA, USA) at room temperature with TMS as an internal standard and CDCl3 or DMSO-d6 as solvents. chemical shifts are expressed in (ppm) and coupling constants (J) in Hz. the 1,4-dioxane was removed under reduced pressure and the mixture was extracted with ethyl acetate. the solution was acidified using 1 M hydrochloric acid solution and extracted three times with ethyl acetate. the combined organic layers were washed with brine, dried over sodium sulfate, filtered, and the solvent was evaporated. 1.03 (s, 3H, H-23), 1.08\u20131.11 (m, 1H, H-15\u2019), 1.16 (s, 3H, H-26), 1.17 (s, 3H, H-25), 1.23\u20131.25 (m, 1H, H-16\u2019), 1.27\u20131.30 (m, 2H, H-22\u2019 and 21\u2019), 1.37 (s, 3H, H-29), 1.42 (s, 3H, H-27), 1.44\u20131.45 ( ferulic acid ethyl ester 3-hydroxy-11-oxo-olean-12-en-30-oate (18) was found as a white solid (573.7 mg, 85%); m.p. 224\u2013226 \u00b0C; 1H-NMR (CDCl3): 0.72\u20130.74. 1.03 (s, 3H, H-23), 1.08\u20131.11 (m, 1H, H-15\u2019), 1.16 (s, 3H, H-26), 1.17 (s, 3H, H-25), 1.23\u20131.25 (m, 1H, H-16\u2019), 1.27\u20131.30 (m, 2H, H-22\u2019 and H-21\u2019), 1.37 (t, J = 5.6 Hz, 3H, CH3), 1.38 (s, 3H, H-29 d, Jtrans = 12.8 Hz, 1H, H-), 7.13 (s, 1H, Bn-H-3), 7.67 (d, J = 6.8 Hz, 1H, Bn-H-6), 13.C-NMR (CDCl3): 200.02, 174.30, 168.32, 166.80, 151.34, 149.95, 147.90, 128.45, 123.01, 121.12, 118.24, 113. m, 1H, H-5), 0.81 (s, 3H, H-28), 0.86 (s, 3H, H-24), 0.94\u20130.98 (m, 1H, H-1\u2019), 1.01 (s, 3H, H-23), 1.06\u20131.09 (m, 1H, H-15\u2019), 1.14 (s, 3H, H-25), 1.19\u20131.21 (m, 1H, H-16\u2019), 1.24\u20131.26 (m, 2H, H-22 d, Jtrans = 16.0 Hz, 1H, H-), 7.55 (d, J = 8.8 Hz, 2H, Bn-H-3 and 5), 7.68 (d, J = 16.0 Hz, 1H, H-), 13C-NMR (CDCl3): 200.03, 174.86, 168.65, 166.93, 162.26, 145.61, 132.27, 129.25, 128.70, 122.12, 3H, H-28), 0.86 (s, 3H, H-24), 0.94\u20130.98 (m, 1H, H-1\u2019), 1.01 (s, 3H, H-23), 1.06\u20131.09 (m, 1H, H-15\u2019), 1.14 (s, 3H, H-25), 1.19\u20131.21 (m, 1H, H-16\u2019), 1.24\u20131.26 (m, 2H, H-22\u2019 and H-21\u2019), 1.34 (t, J = d, Jtrans = 16.0 Hz, 1H, H-), 7.55 (d, J = 8.8 Hz, 2H, Bn-H-2 and 6), 7.67 (d, J = 16.0 Hz, 1H, H-); 13C-NMR (CDCl3): 200.11, 174.78, 168.70, 162.12, 145.40, 132.12, 129.14, 128.61, 121.97, 118. 0.89 (s, 3H, H-24), 0.94\u20130.98 (m, 1H, H-1\u2019), 1.01 (s, 3H, H-23), 1.06\u20131.09 (m, 1H, H-15\u2019), 1.14 (s, 3H, H-26), 1.15 (s, 3H, H-25), 1.19\u20131.21 (m, 1H, H-16\u2019), 1.24\u20131.26 (m, 2H, H-22\u2019 and 21\u2019), 1.36 (s dd, 1H, J = 8.8, 2.0 Hz, Bn-H-4), 7.61 (d, 1H, Jtrans = 16.0 Hz, H-); 13C-NMR (CDCl3): 200.23, 174.38, 167.43, 152.86, 143.66, 139.91, 128.42, 127.56, 127.40, 121.68, 121.68, 121.68, 121.68 0.94\u20130.98 (m, 1H, H-1\u2019), 1.01 (s, 3H, H-23), 1.05\u20131.09 (m, 1H, H-15\u2019), 1.14 (s, 3H, H-26), 1.15 (s, 3H, H-25), 1.19\u20131.21 (m, 1H, H-16\u2019), 1.24\u20131.26 (m, 2H, H-22\u2019 and 21\u2019), 1.33 (t, 3H, J = 7.2 Hz, d, 1H, J = 8.8 Hz, Bn-H-3), 7.36 (d, 1H, J = 8.8, 2.0 Hz, Bn-H-4), 7.60 (d, 1H, Jtrans = 16.0 Hz, H-); 13C-NMR (CDCl3): 200.23, 174.38, 169.22, 167.43, 152.86, 143.66, 139.91, 128.42, 127.56 0.83 (s, 3H, H-28), 0.90 (s, 3H, H-24), 0.97\u20131.00 (m, 1H, H-1\u2019), 1.03 (s, 3H, H-23), 1.08\u20131.12 (m, 1H, H-15\u2019), 1.16 (s, 3H, H-26), 1.17 (s, 3H, H-25), 1.20\u20131.23 (m, 1H, H-16\u2019), 1.27\u20131.28 (m, 2H trans-3-hydroxycinnamic acid ethyl ester 3-hydroxy-11-oxo-olean-12-en-30-oate (24) was found as a white solid (561 mg, 87%); m.p. 173\u2013175 \u00b0C; 1H-NMR (CDCl3): 0.72\u20130.75. 0.90 (s, 3H, H-24), 0.97\u20131.00 (m, 1H, H-1\u2019), 1.03 (s, 3H, H-23), 1.08\u20131.12 (m, 1H, H-15\u2019), 1.16 (s, 3H, H-26), 1.17 (s, 3H, H-25), 1.20\u20131.23 (m, 1H, H-16\u2019), 1.27\u20131.28 (m, 2H, H-22\u2019 and 21\u2019), 1.36 (t t, 1H, J = 6.8, 2.4 Hz, Bn-H-6), 7.42 (s, 1H, Bn-H-4), 7.68 (d, 1H, Jtrans = 16.0 Hz, H-); 13C-NMR (CDCl3): 200.15, 174.76, 168.73, 166.96, 151.00, 145.48, 135.85, 129.73, 128.50, 125.49, 123. the reaction mixture was stirred at 0 \u00b0C for another 1 h. the appropriate GA derivative 17\u201324 (0.5 mmol) was then added to the mixture. the reaction mixture was then stirred at room temperature for 12 h. 1.67 (dd, J = 13.6, 4.4 Hz, 1H, H-19\u2019), 1.70\u20131.72 (m, 1H, H-2\u2019), 1.73\u20131.74 (m, 1H, H-7), 1.89 (ddd, J = 14.8, 14.8, 5.6 Hz, 1H, H-16), 2.03\u20132.05 (m, 1H, H-21), 2.09\u20132.11 (m, 1H, H-15), 2.12 (s, 3H, SCH 28.40, 123.02, 121.15, 118.31, 113.49, 109.10, 81.93, 79.69, 61.54, 55.69, 54.94, 52.73, 51.67, 48.00, 45.33, 44.47, 43.11, 41.18, 38.06, 38.02, 37.40, 36.86, 32.64, 32.10, 31.81, 31.15, 29. s, 3H, H-25), 1.23\u20131.25 (m, 1H, H-16\u2019), 1.27\u20131.30 (m, 2H, H-22\u2019 and 21\u2019), 1.42 (s, 3H, H-29), 1.46 (s, 9H, Boc-CH3), 1.49\u20131.52 (m, 1H, H-22), 1.54\u20131.56 (m, 1H, H-7\u2019), 1.58\u20131.60 (m, 1H, H-6\u2019), 1.62 7.02 (d, J = 8.0 Hz, 1H, Bn-H-5), 7.13 (s, 1H, Bn-H-3), 7.68 (d, Jtrans = 16.0 Hz, 1H, H-); 13C-NMR (CDCl3): 199.82, 174.40, 171.82, 169.17, 166.85, 154.90, 151.40, 149.94, 145.89, 128.40, 1H-NMR (CDCl3): 0.80\u20130.83 (m, 1H, H-5), 0.88 (s, 3H, H-28), 0.89 (s, 3H, H-24), 1.05\u20131.08 (m, 1H, H-15\u2019), 1.11\u20131.13 (m, 1H, H-1\u2019), 1.15 (s, 3H, H-25), 1.20\u20131.23 (m, 1H, H-16\u2019), 1.26\u20131.28 (m, 2H m, 1H, SCH2), 2.55\u20132.57 (m, 2H, SCH2), 2.81 (ddd, J = 14.0, 3.2, 3.2 Hz, 1H, H-1), 3.86 (s, 3H, OCH3), 4.27 (q, J = 7.2 Hz, 2H, CH2CH3), 4.57 (dd, J = 11.6, 4.8 Hz, 1H, H-3), 5.12 (t, J = 8.4 ethyl ester 3-(Boc-l-selenomethionine)-11-oxo-olean-12-en-30-oate is a colourless powder. found from 18 and N-Boc-l-selenomethionine as a colourless powder. 1.73\u20131.75 (m, 1H, H-2\u2019), 1.76\u20131.78 (m, 1H, H-7), 1.80\u20131.83 (m, 1H, H-2), 1.89 (ddd, J = 14.4, 14.4, 5.2 Hz, 1H, H-16), 2.97\u20131.99 (m, 1H, H-21), 2.00\u20132.01 (m, 1H, H-15), 2.02 (s, 3H, SeCH3), 2.12 (dd, trans-4-Hydroxycinnamic acid methyl ester 3-(Boc-l-methionine)-11-oxo-olean-12-oate (29) found from 19 and N-Boc-l-methionine as a colourless powder. 1.23\u20131.25 (m, 1H, H-16\u2019), 1.27\u20131.31 (m, 2H, H-22\u2019 and 21\u2019), 1.37 (s, 3H, H-29), 1.47 (s, 9H, Boc-CH3), 1.48\u20131.50 (m, 1H, H-22), 1.51\u20131.53 (m, 1H, H-7\u2019), 1.60\u20131.62 (m, 1H, H-6\u2019), 1.64\u20131.66 (m, 1H, d, J = 8.4 Hz, 2H, Bn-H-3 and 5), 7.70 (d, Jtrans = 16.0 Hz, 1H, H-); 13C-NMR (CDCl3): 199.80, 174.83, 172.02, 168.76, 166.90, 162.24, 155.22, 145.41, 132.17, 129.13, 128.58, 121.92, 118.41, 81.98 400 MHz, CDCl3): 0.82\u20130.85 (m, 1H, H-5), 0.88 (s, 3H, H-28), 0.92 (s, 3H, H-24), 1.08\u20131.11 (m, 1H, H-15\u2019), 1.13\u20131.15 (m, 1H, H-1\u2019), 1.17 (s, 3H, H-26), 1.19 (s, 3H, 3H, H-25), 1.22\u20131.26 (m, 1H, Hz, 1H, H-1, 3.83 (s, 3H, COOCH3), 4.59 (dd, J = 10.8, 5.6 Hz, 1H, H-3), 5.13 (t, J = 9.2 Hz, 1H, CHCOO), 5.70 (s, 1H, H-12), 6.43 (d, Jtrans = 16.0 Hz, 1H, H-), 7.10 (d, J = 8.4 Hz, 2H, Bn-H-2 and amic acid ethyl ester 3-(Boc-l-methionine)-11-oxo-olean-12-en-30-oate (31) Obtained from 20 and N-Boc-l-methionine as a colourless powder (359 mg, 82%); m.p. 102\u2013104 \u00b0C; 1H-NMR (CDCl3): 0.82\u20130.85. 2.10\u20132.11 (m, 1H, H-15), 2.27 (s, 3H, SCH3), 2.39 (s, 1H, H-9), 2.57\u20132.46 (m, 1H, SCH2), 2.83 (ddd, J = 13.6, 2.8, 2.8 Hz, 1H, H-1), 4.29 (q, J = 7.2 Hz, 2H, CH2CH3), 4.59 (dd, J = 11.2, 5.2 Hz, 1 trans-4-Hydroxycinnamic acid ethyl ester 3-(Boc-l-selenomethionine)-11-oxo-olean-12-en-30-oate (32). Obtained from 20 and N-Boc-l-selenomethionine as a colourless powder. 1.60\u20131.62 (m, 1H, H-6\u2019), 1.64\u20131.66 (m, 1H, H-6\u2019), 1.73\u20131.75 (m, 1H, H-2\u2019), 1.77\u20131.79 (m, 1H, H-7), 1.81\u20131.84 (m, 1H, H-2), 1.89 (ddd, J = 14.8, 14.8, 5.6 Hz, 1H, H-16), 1.92\u20131.94 (m, 1H, H-21), 1.97 Isoferulic acid methyl ester 3-(Boc-l-methionine)-11-oxo-olean-12-en-30-oate. found from 21 and N-Boc-l-methionine as a colourless powder. 1.28\u20131.29 (m, 2H, H-22\u2019 and 21\u2019), 1.38 (s, 3H, H-29), 1.46 (s, 9H, Boc-CH3), 1.49 (m, 1H, H-22), 1.53 (m, 1H, H-7\u2019), 1.58 (m, 1H, H-6\u2019), 1.62 (m, 1H, H-6\u2019), 1.73 (m, 1H, H-2\u2019), 1.77 (m, 1H, H-7), 13C-NMR (CDCl3): 199.95, 174.34, 171.83, 169.03, 166.96, 154.82, 152.83, 143.64, 138.11, 128.42, 127.43, 127.38, 121.70, 116.21, 112.26, 81.90, 79.66, 61.56, 55.71, 54.87, 52.69, 51.53, 47.93, 45.29 1H, H-5), 0.89 (s, 3H, H-24), 0.92 (s, 3H, H-24), 1.07\u20131.11 (m, 1H, H-15\u2019), 1.14\u20131.16 (m, 1H, H-1\u2019), 1.18 (s, 3H, H-25), 1.22\u20131.26 (m, 1H, H-16\u2019), 1.28\u20131.29 (m, 2H, H-22\u2019 and 21\u2019), 1.38 (s, 3H, H-29 t, 1H, J = 8.4 Hz, CHCOO), 5.73 (s, 1H, H-12), 6.98 (d, 1H, J = 8.4 Hz, Bn-H-3), 7.19 (d, 1H, J = 8.4, 2.0 Hz, Bn-H-4), 7.63 (d, 1H, J = 16.0 Hz, H-); 13C-NMR (CDCl3): 199.95, 174.34, 171.75, 169.00, m.p. 111\u2013114 \u00b0C; 1H-NMR (CDCl3): 0.80\u20130.83 (m, 1H, H-5), 0.88 (s, 3H, H-28), 0.89 (s, 3H, H-24), 1.05\u20131.09 (m, 1H, H-15\u2019), 1.14\u20131.16 (m, 1H, H-1\u2019), 1.16 (s, 3H, H-26), 1.17 (s, 3H, H-25), 2.43 (m, 1H, H-19), 2.55 (m, 2H, SCH2), 2.81 (ddd, 1H, J = 14.0, 3.2, 3.2 Hz, H-1), 3.86 (s, 3H, OCH3), 4.25 (q, 2H, J = 7.2 Hz, CH2CH3), 4.57 (dd, 1H, J = 11.6, 4.8 Hz, H-3), 5.12 (t, 1H, J = 8. Isoferulic acid methyl ester 3-(Boc-l-selenomethionine)-11-oxo-olean-12-en-30-oate (36) found from 22 and N-Boc-l-selenomethionine as colourless powder. found from 22 and N-Boc-l-selenomethionine as a colourless powder. 1.64 (dd, 1H, J = 13.6, 4.4 Hz, H-19\u2019), 1.75 (m, 1H, H-7), 1.78 (m, 1H, H-2), 1.88 (ddd, 1H, J = 14.4, 14.4, 5.2 Hz, H-16), 1.96 (m, 1H, H-21), 1.98(m, 1H, H-15), 2.10 (dd, 1H, J = 13.2, 4.0 Hz, H-18), 2.37 127.40, 127.38, 121.65, 116.20, 112.26, 81.93, 79.80, 61.65, 60.65, 55.72, 54.89, 52.66, 47.94, 45.27, 44.27, 43.06, 41.08, 38.96, 38.86, 37.82, 36.87, 32.61, 32.12, 31.83, 31.14, 29.61, 28.48 1.23\u20131.25 (m, 1H, H-16\u2019), 1.26\u20131.28 (m, 2H, H-22\u2019 and 21\u2019), 1.39 (s, 3H, H-29), 1.42 (s, 3H, H-27), 1.47 (s, 9H, Boc-CH3), 1.50 (m, 1H, H-22), 1.53 (m, 1H, H-7\u2019), 1.61 (m, 1H, H-6\u2019), 1.64 (m, 1H, t, 1H, Jtrans = 7.6 Hz, Bn-H-5), 7.70 (d, 1H, Jtrans = 16.0 Hz, H-); 13C-NMR (CDCl3): 199.80, 174.87, 171.91, 168.82, 167.02, 155.24, 151.11, 143.61, 135.95, 129.88, 128.57, 125.50, 120.67, 118.89, 0.82\u20130.85 (m, 1H, H-5), 0.90 (s, 3H, H-24), 0.92 (s, 3H, H-24), 1.08\u20131.11 (m, 1H, H-15\u2019), 1.13\u20131.15 (m, 1H, H-15\u2019), 1.17(s, 3H, H-26), 1.19 (s, 3H, H-25), 1.23\u20131.25 (m, 1H, H-16\u2019), 1.26\u20131.28 (m, 2 trans-3-Hydroxycinna is a trans-3-Hydroxycinna gene. it is a trans-3-Hydroxycinna gene. it is the first trans-3-Hydroxycinna gene found in the u.s. mic acid ethyl ester 3-(Boc-l-methionine)-11-oxo-olean-12-en-30-oate (39) Obtained from 24 and N-Boc-l-methionine as a colourless powder (341 mg, 78%); m.p. 107\u2013108 \u00b0C. 2.28 (dd, 1H, J = 13.6, 4.4 Hz, H-18), 2.39 (s, 1H, H-9), 2.46 (m, 2H, SCH2), 2.84 (q, 2H, J = 7.2 Hz, CH2CH3), 4.59 (dd, 1H, J = 11.2, 5.2 Hz, H-3), 5.15 (t, 1H, J = 9.2 Hz, CHCOO), 7.08 (dt, 1H, trans-3-Hydroxycinnamic acid ethyl ester 3-(Boc-l-selenomethionine)-11-oxo-olean-12-en-30-oate. found from 24 and N-Boc-l-selenomethionine as colourless powder. 1.61 (m, 1H, H-6\u2019), 1.64 (m, 1H, H-6), 1.70 (dd, 1H, J = 13.6, 4.4 Hz, H-19\u2019), 1.74 (m, 1H, H-2\u2019), 1.77 (m, 1H, H-7), 1.80 (m, 1H, H-2), 1.90 (ddd, 1H, J = 14.8, 14.8, 5.6 Hz, H-16), 1.98 (m, 1H, H-21 compounds 25\u201340 (0.25 mmol) were dissolved in dry DCM. after saturation with dry hydrogen chloride gas for 10 min, stirring at room temperature was then continued for 24 h. resulting precipitate was filtered and washed with ethyl acetate until no parent substance can be detected. 0.71\u20130.74 (m, 1H, H-5), 0.83 (s, 3H, H-28), 0.85 (s, 3H, H-24), 0.90\u20130.93 (m, 1H, H-15\u2019), 1.00\u20131.03 (m, 1H, H-1\u2019), 1.07 (s, 3H, H-26), 1.08 (s, 3H, H-25), 1.12\u20131.14 (m, 1H, H-16\u2019), 1.20\u20131.24 (m, s, 3H, OCH3), 4.47 (dd, J = 11.2, 5.2 Hz, 1H, H-3), 6.72 (d, Jtrans = 16.0 Hz, 1H, H-), 7.11 (d, J = 8.0, 1.6 Hz, 1H, Bn-H-5), 7.55 (d, J = 1.6 Hz, 1H, Bn-H-6), 7.67 (d, J = 16.0 Hz, 1H, Bn- ic acid methyl ester 3-(l-selenomethionine)-11-oxo-olean-12-en-30-oate hydrochloride (42) Obtained from 26 as a white solid (156 mg, 77%); m.p. 210\u2013213 \u00b0C; 1H-NMR (DMSO-d6): 0.71\u20130.74 (m, 1H, H-5), 0.83 (s, 3H, H-28), 0.84 (s s, 1H, H-9, 2.54\u20132.56 (m, 1H, H-19), 2.57\u20132.59 (m, 2H, SeCH2), 2.64 (ddd, J = 13.2, 3.2, 3.2 Hz, 1H, H-1), 3.74 (s, 3H, COOCH3), 3.84 (s, 3H, OCH3), 4.48 (dd, J = 11.2, 5.2 Hz, 1H, H-3), 5.46 (s ethyl ester 3-(l-methionine)-11-oxo-olean-12-en-30-oate hydrochloride. found from 27 as a white solid (142 mg, 73%); m.p. 191\u2013194 \u00b0C. 1.86 (ddd, J = 14.4, 14.4, 5.6 Hz, 1H, H-16), 1.92-1.93 (m, 1H, H-21), 1.94\u20131.96 (m, 1H, H-15), 2.03 (s, 3H, SCH3), 2.28\u20132.31 (m, 1H, H-18), 2.42 (s, 1H, H-9), 2.54\u20132.55 (m, 1H, H-19), 2.56\u20132.59 (m, 2H ethyl ester 3-(l-selenomethionine)-11-oxo-olean-12-en-30-oate hydrochloride (44) found from 28 as a white solid (160 mg, 78%); found: C, 67.00; H, 8.13; N, 1.61; S, 3.85%. 1.49\u20131.50 (m, 1H, H-7\u2019), 1.51\u20131.52 (m, 1H, H-6\u2019), 1.54\u20131.56 (m, 1H, H-6\u2019), 1.65 (dd, J = 13.2, 4.0 Hz, 1H, H-19\u2019), 1.68-1.69 (m, 1H, H-2\u2019), 1.70\u20131.73 (m, 1H, H-7), 1.79\u20131.82 (m, 1H, H-2), 1.86 ( trans-4-Hydroxycinnamic acid methyl ester 3-(l-methionine)-11-olean-12-en-30-oate hydrochloride (45) found from 29 as a white solid (143 mg, 76%); found: C, 63.47; H, 7.71; N, 1.57%. 1.08 (s, 3H, H-25), 1.17\u20131.20 (m, 1H, H-16\u2019), 1.24\u20131.27 (m, 2H, H-22\u2019 and 21\u2019), 1.33 (s, 3H, H-29), 1.45\u20131.48 (m, 1H, H-7\u2019), 1.52-1.53 (m, 1H, H-6\u2019), 1.54\u20131.57 (m, 1H, H-6\u2019), 1.68\u20131.70 (m, 1H, H-2 d, 174.83, 174.01, 168.76, 166.98, 162.27, 145.45, 132.17, 129.13, 128.58, 121.98, 118.45, 81.48, 61.73, 54.94, 53.68, 51.83, 48.43, 45.36, 44.39, 43.24, 41.10, 38.16, 38.12, 37.78, 37.15, 32. 90\u20130.93 (m, 1H, H-15\u2019), 1.00\u20131.03 (m, 1H, H-1\u2019), 1.06 (s, 3H, H-25), 1.16\u20131.20 (m, 1H, H-16\u2019), 1.23\u20131.20 (m, 1H, H-16\u2019), 1.33 (s, 3H, H-29), 1.41 (s, 3H, H-27), 1.44\u20131.46 (m, 1H, H-7\u2019), 1.52\u20131.5 d, J = 8.8 Hz, 2H, Bn-H-2 and 5), 7.81 (d, Jtrans = 16.0 Hz, 2H, H-); 13C-NMR (DMSO-d6): 199.83, 174.83, 173.95, 168.67, 167.03, 162.25, 145.44, 132.20, 129.13, 128.58, 121.97, 118.48, 81.52, 61 0.84 (s, 3H, H-24), 0.85 (s, 3H, H-24), 0.91\u20130.94 (m, 1H, H-15\u2019), 1.00\u20131.04 (m, 1H, H-1\u2019), 1.07 (s, 3H, H-26), 1.08 (s, 3H, H-25), 1.13\u20131.14 (m, 1H, H-16\u2019), 1.18\u20131.22 (m, 2H, H-22\u2019 and 21\u2019), 1.27 (t, trans-4-Hydroxycinnamic acid ethyl ester 3-(l-selenomethionine) ethyl ester 3-(l-selenomethionine)-11-olean-12-en-30-oate hydro. m.p. 208\u2013211 \u00b0C; 1H-NMR (DMSO-d6): 0.71\u20130.74 (m, 1H, H-5), 0.83 (s, 3H, H-28), 0.84 (s, 3H, H-24), 0.91\u20130.94 (m, 1H, H-15\u2019), 1.00\u20131.04 (m, 1H, H-1\u2019), 1.07 (s, 3H, H-25), 1.13\u20131.14 (m, 1H 2.56\u20132.59 (m, 2H, SeCH2), 2.64 (ddd, J = 13.2, 3.2, 3.2 Hz, 1H, H-1), 4.20 (q, J = 7.2 Hz, 2H, CH2CH3), 4.47 (dd, J = 11.2, 5.2 Hz, 1H, H-3), 5.46 (s, 1H, H-12), 6.63 (d, Jtrans = 16.0 Hz, 1H, H-), 7.67 Isoferulic acid methyl ester 3-(l-methionine)-11-oxo-olean-12-en-30-oate hydrochloride (49) Obtained from 33 as a white solid (143 mg, 75%) m, 2H, SCH2), 2.64 (ddd, 1H, J = 12.8, 3.2, 3.2 Hz, H-1), 3.72 (s, 3H, COOCH3), 3.82 (s, 3H, OCH3), 4.47 (dd, 1H, J = 11.2, 5.2 Hz, H-3), 5.48 (s, 1H, H-12), 6.60 (d, 1H, Jtrans = 16.0 Hz, H-), 7.18 Isoferulic acid methyl ester 3-(l-selenomethionine)-11-oxo-olean-12-en-30-oate hydrochloride (50) found from 34 as a white solid (158 mg, 78%); m.p. 201\u2013203 \u00b0C; 1H-NMR (DMSO-d6) 2.28 (m, 1H, H-18), 2.55 (m, 1H, H-19), 2.58 (m, 2H, SeCH2), 2.64 (ddd, 1H, J = 12.8, 3.2, 3.2 Hz, H-1), 3.72 (s, 3H, COOCH3), 3.82 (s, 3H, OCH3), 4.47 (dd, 1H, J = 11.2, 5.2 Hz, H-3), 5.48 (s, 1H, Isoferulic acid ethyl ester 3-(l-methionine)-11-oxo-olean-12-en-30-oate hydrochloride (51). Found from 35 as a white solid (144 mg, 74%); m.p. 192\u2013195 \u00b0C; 1H-NMR (DMSO-d6): 0.71\u20130.74 (m, 1H, H-5), 0.84 (s, 3H, H-28), 0.85 dd, 1H, J = 14.4, 14.4, 5.6 Hz, H-16), 1.89 (m, 1H, H-21), 1.92 (m, 1H, H-15), 2.04 (s, 3H, SCH3), 2.29 (m, 1H, H-18), 2.43 (m, 1H, H-9), 2.64 (m, 2H, SCH2), 2.64 (ddd, 1H, J = 13.6, 3.6, 3.6 Hz, H-1 Isoferulic acid ethyl ester 3-(l-selenomethionine)-11-oxo-olean-12-en-30-oate hydrochloride (52) found from 36 as a white solid (154 mg, 75%). 1.54 (m, 1H, H-6), 1.64 (dd, 1H, J = 13.2, 4.0 Hz, H-19\u2019), 1.70 (m, 1H, H-7), 1.80 (m, 1H, H-2), 1.86 (ddd, 1H, J = 14.4, 14.4, 5.6 Hz, H-16), 1.89 (m, 1H, H-21), 1.92 (m, 1H, H-15), 1.94 (s, 3H, SeCH3), trans-3-Hydroxycinnamic acid methyl ester 3-(l-methionine)-11-oxo-olean-12-en-30-oate hydrochloride. found from 37 as a white solid (145 mg, 79%); found from 37 as a white solid. 1.45 (m, 1H, H-22), 1.49 (m, 1H, H-7\u2019), 1.52 (m, 1H, H-6\u2019), 1.54 (m, 1H, H-6\u2019), 1.65 (dd, 1H, J = 13.2, 4.0 Hz, H-19\u2019), 1.68 (m, 1H, H-2\u2019), 1.70 (m, 1H, H-7), 1.79 (m, 1H, H-2), 1.86 (ddd, 1H, 135.91, 129.83, 128.57, 125.59, 123.26, 120.65, 118.94, 81.50, 61.61, 54.92, 53.63, 51.76, 48.36, 45.32, 44.28, 43.15, 40.94, 38.57, 38.07, 37.72, 36.84, 32.41, 31.88, 31.07, 29.95, 28.57, 28.26, 1.14 (m, 1H, H-16\u2019), 1.17\u20131.20 (m, 2H, H-22\u2019 and 21\u2019), 1.34 (s, 3H, H-29), 1.44 (m, 1H, H-22), 1.49 (m, 1H, H-7\u2019), 1.52 (m, 1H, H-6\u2019), 1.54 (m, 1H, H-6\u2019), 1.68 (m, 1H, H-2\u2019), 1.70 (m, 1H, H-7), 1. 13C-NMR (DMSO-d6): 199.82, 174.87, 173.89, 168.78, 167.09, 151.12, 143.63, 136.03, 129.88, 128.55, 125.53, 123.25, 120.67, 118.97, 81.56, 61.61, 54.93, 53.60, 51.76, 48.37, 45.32, 44.26, 43.16 1.04 (m, 1H, H-1\u2019), 1.07 (s, 3H, H-26), 1.08 (s, 3H, H-25), 1.12\u20131.14 (m, 1H, H-16\u2019), 1.27 (t, 3H, H-29), 1.42 (s, 3H, H-27), 1.45 (m, 1H, H-22), 1.49 (m, 1H, H-7\u2019), 1.52 (m, 1H, H-6\u2019), 1.55 (m trans-3-Hydroxycinnamic acid ethyl ester 3-(l-selenomethionine)-11-olean-12-en-30-oate hydrochloride (56) found from 40 as a white solid (149 mg, 75%) 0.72\u20130.75 (m, 1H, H-5), 0.84 (s, 3H, H-28), 0.85 (s, 3H, H-24), 0.91\u20130.93 (m, 1H, H-15\u2019), 1.01\u20131.04 (m, 1H, H-1\u2019), 1.07 (s, 3H, H-26), 1.08 (s, 3H, H-25), 1.13\u20131.15 (m, 1H, H-16\u2019), 1.17\u20131.21 (m, anticancer assays The cytotoxicities of the compounds were evaluated by the MTT assay, which is based on the. three lines of cells (MCF-7, MDA-MB-231 and hTERT-RPE1) were cultured in 96 well plates for 24 h with a density of 0.8 104 cells/well. the medium was incubated with 20 L of 5 mg/mL MTT solution for 3 h in a humidified incubator containing 5% CO2. cell viability was expressed as a percentage of the value in control cultures. 5\u201312 Ferulic acid (1) or trans-4-hydroxycinnamic acid (2) or isoferulic acid (3) or trans-3-hydroxycinnamic acid (4) were refluxed in methanol or ethanol for 12 h. the reaction mixture was concentrated in vacuo and the residue was dissolved in ethyl acetate. the residue was purified by column chromatography on silica gel using ethyl acetate/petroleum CI (230 mg, 1.2 mmol), DMAP (24 mg, 0.2 mmol) and compounds 5\u201312 (1 mmol) were added to the solution, and then the reaction mixture was stirred at room temperature for 12 h. the organic layer was washed with 1 M HCl solution and concentrated in vacuo. 1.77\u20131.79 (m, 1H, H-2), 1.89 (ddd, J = 14.4, 14.4, 5.2 Hz, 1H, H-16), 2.02\u20132.04 (m, 1H, H-21), 2.08\u20132.10 (m, 1H, H-15), 2.12 (dd, J = 13.2, 4.0 Hz, 1H, H-18), 2.37 (s, 1H, H-9), 2.43\u20132.45 (m, 1H, H-19), 2. ferulic acid ethyl ester 3-hydroxy-11-oxo-olean-12-en-30-oate (18) was obtained from GA and ferulic acid ethyl ester as a white solid. 1.65 (dd, J = 13.2, 4.0 Hz, 1H, H-19\u2019), 1.70\u20131.72 (m, 1H, H-7), 1.89 (m, 1H, H-2), 2.03\u20132.05 (m, 1H, H-21), 2.08\u20132.10 (m, 1H, H-15), 2.12 (dd, J = 12.8, 3.6 Hz, 1H, H-18), 2.37 (s, 1H, H-9), 2.43\u20132.45 ( trans-4-hydroxycinnamic acid methyl ester 3-hydroxy-11-oxo-olean-12-en-30-oate was found as a white solid (530 mg, 84%); m.p. 202\u2013205 \u00b0C; 1H-NMR (CDCl3). 1.60\u20131.62 (m, 1H, H-6), 1.64 (dd, J = 13.2, 4.0 Hz, 1H, H-19\u2019), 1.72\u20131.74 (m, 1H, H-7), 1.75\u20131.78 (m, 1H, H-2), 1.87 (ddd, J = 14.8, 14.8, 5.6 Hz, 1H, H-16), 2.04\u20132.06 (m, 1H, H-21), 2.11\u20132.13 (m, 1H, trans-4-hydroxycinnamic acid ethyl ester 3-hydroxy-11-oxo-olean-12-en-30-oate (20) was found as a white solid (548.1 mg, 85%); m.p. 195\u2013196 \u00b0C. 1.60\u20131.62 (m, 1H, H-6\u2019), 1.67\u20131.69 (m, 1H, H-2\u2019), 1.72\u20131.74 (m, 1H, H-7), 1.75\u20131.78 (m, 1H, H-2), 1.86 (ddd, J = 14.4, 14.4, 5.2 Hz, 1H, H-16), 2.04\u20132.06 (m, 1H, H-21), 2.12\u20132.14 (m, 1H, H-15), 2.24 ( isoferulic acid methyl ester 3-hydroxy-11-oxo-olean-12-en-30-oate was found as a white solid (575 mg, 87%); m.p. 215\u2013217 \u00b0C; 1H-NMR (CDCl3): 0.70\u20130.72 (m, 1H, H-5), 0.81 (s, 3H, H-28), 0.89 (s, 3H, H-24), 0.94\u20130.98 (m, 1H 1.67 (m, 1H, H-2\u2019), 1.70 (m, 1H, H-7), 1.88 (ddd, 1H, J = 14.4, 14.4, 5.2 Hz, H-16), 2.06 (m, 1H, H-21), 2.10 (m, 1H, H-15), 2.13 (dd, 1H, J = 13.2, 4.0 Hz, H-18), 2.35 (s, 1H, H-9), 2.42 (m, 1H, H-19), 2. isoferulic acid ethyl ester 3-hydroxy-11-oxo-olean-12-en-30-oate (22) found as a white solid (567 mg, 84%); m.p. 210\u2013213 \u00b0C; 1H-NMR (CDCl3). 1.64 (dd, 1H, J = 13.2, 4.0 Hz, H-19\u2019), 1.67 (m, 1H, H-7), 1.75 (m, 1H, H-2), 1.87 (m, 1H, H-2), 1.87 (m, 1H, 1H, J = 14.0, 14.0, 4.8 Hz, H-16), 2.06 (m, 1H, H-21), 2.10 (m, 1H, H-15), 2.13 (dd, 1H, trans-3-hydroxycinnamic acid methyl ester 3-hydroxy-11-oxo-olean-12-en-30-oate was found as a white solid (511 mg, 81%); m.p. 188\u2013190 \u00b0C; 1H-NMR (CDCl3): 0.72\u20130.75 (m, 1H, H-5), 0.83 (s, 3H, H-28), 0.97\u20131.00 (m, 1H, H-15\u2019), 1.16 ( 1.66 (dd, 1H, J = 13.2, 4.0 Hz, H-19\u2019), 1.74 (m, 1H, H-7), 1.89 (ddd, 1H, J = 14.8, 14.8, 5.6 Hz, H-16), 2.08 (m, 1H, H-21), 2.16 (m, 1H, H-15), 2.43 (m, 1H, H-19), 2.81 (dd, 1H, J = 12.8, 2.8, 2.8 Hz, H-1 trans-3-hydroxycinnamic acid ethyl ester 3-hydroxy-11-oxo-olean-12-en-30-oate was found as a white solid (561 mg, 87%); m.p. 173\u2013175 \u00b0C; 1H-NMR (CDCl3): 0.72\u20130.75 (m, 1H, H-5), 0.83 (s, 3H, H-28), 0.97\u20131.00 (m, 1H, H-15\u2019 1.62 (m, 1H, H-6), 1.66 (dd, 1H, J = 13.2, 4.0 Hz, H-19\u2019), 1.74 (m, 1H, H-7), 1.89 (ddd, 1H, J = 14.4, 14.4, 5.2 Hz, H-16), 2.08 (m, 1H, H-21), 2.16 (m, 1H, H-15), 2.43 (m, 1H, H-19), 2.81 (dd, 1H, J = 13. the protected amino acid (N-Boc-l-methionine or N-Boc-l-selenomethionine, 0.5 mmol) was dissolved in dry DCM and stirred at 0 \u00b0C for 5 min. then EDCI (115 mg, 0.6 mmol) and DMAP (12 mg, 0.1 mmol) were then added to the mixture. 1H-NMR (CDCl3): 0.82\u20130.84 (m, 1H, H-5), 0.89 (s, 3H, H-28), 0.91 (s, 3H, H-24), 1.07\u20131.11 (m, 1H, H-15\u2019), 1.14\u20131.16 (m, 1H, H-1\u2019), 1.17 (s, 3H, H-25), 1.22\u20131.25 (m, 1H, H-16\u2019), 1.27\u20131.31 (m, 2H SCH2), 2.83 (ddd, J = 13.6, 2.8, 2.8 Hz, 1H, H-1), 3.88 (s, 3H, OCH3), 4.80 (dd, J = 11.2, 5.2 Hz, 1H, H-3), 5.14 (t, J = 8.4 Hz, 1H, COOCH3), 5.73 (s, 1H, H-12), 6.42 (d, Jtrans = 16.0 Hz, 1H, H-), 7. methyl ester 3-(Boc-l-selenomethionine)-11-oxo-olean-12-en-30-oate (26) found from 17 and N-Boc-l-selenomethionine as a colourless powder (389 mg, 83%); m.p. 125\u2013127 \u00b0C. 1.88 (ddd, J = 14.8, 14.8, 5.6 Hz, 1H, H-16), 1.89-1.92 (m, 1H, H-21), 1.98\u20132.00 (m, 1H, H-15), 2.02 (s, 3H, SeCH3), 2.12 (dd, J = 13.6, 4.4 Hz, 1H, H-18), 2.39 (s, 1H, H-9), 2.44\u20132.47 (m, 1H, H-19), 2.58\u2013 .67, 48.02, 45.34, 44.47, 43.15, 41.20, 38.10, 38.06, 37.43, 36.86, 32.65, 32.07, 31.84, 31.15, 29.64, 28.50, 28.27, 28.41, 26.35, 23.45, 23.30, 18.60, 17.32, 16.75, 16.30, 15.37; ESI-MS: m/z = 962. 1.39 (s, 3H, H-27), 1.45 (s, 9H, Boc-CH3), 1.48\u20131.50 (m, 1H, H-22), 1.51\u20131.54 (m, 1H, H-7\u2019), 1.58\u20131.60 (m, 1H, H-6\u2019), 1.61\u20131.63 (m, 1H, H-6\u2019), 1.71\u20131.73 (m, 1H, H-2\u2019), 1.75\u20131.77 (m, 1H, H-7), d, Jtrans = 16.0 Hz, 1H, H-; 13C-NMR (CDCl3): 199.92, 174.28, 171.90, 169.32, 166.77, 155.10, 151.33, 149.92, 145.86, 128.38, 123.00, 121.10, 118.30, 113.49, 109.10, 82.03, 79.80, 61.60, 0.82\u20130.85 (m, 1H, H-5), 0.90 (s, 3H, H-24), 0.92 (s, 3H, H-24), 1.07\u20131.10 (m, 1H, H-15\u2019), 1.11\u20131.13 (m, 1H, H-1\u2019), 1.17 (s, 3H, H-26), 1.19 (s, 3H, H-25), 1.22\u20131.26 (m, 1H, H-16\u2019), 1.27\u20131.30 (m, 2 d, J = 14.0, 3.2, 3.2 Hz, 1H, H-1, 3.88 (s, 3H, OCH3), 4.59 (q, J = 11.6, 4.8 Hz, 1H, H-3), 5.13 (t, J = 8.4 Hz, 1H, CHCOO), 5.73 (s, 1H, H-12), 6.41 (d, J = 8.0 Hz, 1H, Bn-H-5), 7.13 (s, 1H, trans-4-Hydroxycinnamic acid methyl ester 3-(Boc-l-methionine)-11-oxo-olean-12-oate (29) found from 19 and N-Boc-l-methionine as a colourless powder (362 mg, 84%); found from 19 and N-Boc-l-methionine as a colourless powder. 1.89 (ddd, J = 15.2, 15.2, 6.0 Hz, 1H, H-16), 2.06\u20132.08 (m, 1H, H-21), 2.10\u20132.11 (m, 1H, H-15), 2.12-2.15 (s, 3H, SCH3), 2.26 (dd, J = 14.0, 4.8 Hz, 1H, H-18), 2.39 (s, 1H, H-9), 2.43\u20132.46 (m, 1H, H-19 trans-4-Hydroxycinnamic acid methyl ester 3-(Boc-l-selenomethionine)-11-oxo-olean-12-en-30-oate. found from 19 and N-Boc-l-selenomethionine as a colourless powder. 1H, H-22), 1.53\u20131.55 (m, 1H, H-7\u2019), 1.64\u20131.66 (m, 1H, H-6\u2019), 1.68 (dd, J = 13.6, 4.4 Hz, 1H, H-19\u2019), 1.74\u20131.76 (m, 1H, H-2\u2019), 1.77\u20131.79 (m, 1H, H-7), 1.81\u20131.84 (m, 1H, H-2), 1.90 (ddd, J = 15.2, 15. trans-4-Hydroxycinnamic acid ethyl ester 3-(Boc-l-methionine)-11-oxo-olean-12-oate (31) found from 20 and N-Boc-l-methionine as a colourless powder. found from 20 and N-Boc-l-methionine as a colourless powder. 18 (s, 3H, H-25), 1.23\u20131.26 (m, 1H, H-16\u2019), 1.28\u20131.30 (m, 2H, H-22\u2019 and 21\u2019), 1.36 (s, 3H, H-29), 1.42 (s, 3H, H-27), 1.47 (s, 9H, Boc-CH3), 1.49\u20131.50 (m, 1H, H-22), 1.51\u20131.54 (m, 1H, H-7\u2019), 1.61\u20131.6 trans = 16.0 Hz, 1H, H-), 7.57 (d, J = 8.4 Hz, 2H, Bn-H-3 and 5), 7.69 (d, Jtrans = 16.0 Hz, 1H, H-); 13C-NMR (CDCl3): 199.83, 174.76, 171.93, 168.81, 166.79, 162.11, 155.21, 145.37, 132.13, 129.14, 128.5 onine as a colourless powder (383 mg, 83%); m.p. 110\u2013112 \u00b0C; 1H-NMR (CDCl3): 0.82\u20130.85 (m, 1H, H-5), 0.89 (s, 3H, H-28), 0.91 (s, 3H, H-24), 1.08\u20131.11 (m, 1H, H-15\u2019), 1.13\u20131.15 (m, 1H, H-1\u2019), 1.17 (s, 3H, 2.46\u20132.49 (m, 1H, H-19), 2.57\u20132.60 (m, 2H, SeCH2), 2.84 (ddd, J = 13.6, 2.8, 2.8 Hz, 1H, H-1), 4.29 (q, J = 7.2 Hz, 2H, CH2CH3), 4.59 (dd, J = 11.2, 5.2 Hz, 1H, H-3), 5.13 (t, J = 9.2 Hz, 1H, CHCOO Isoferulic acid methyl ester 3-(Boc-l-methionine)-11-oxo-olean-12-en-30-oate. found from 21 and N-Boc-l-methionine as a colourless powder. found from 21 and N-Boc-l-methionine as a colourless powder. m, 1H, H-21), 2.10 (m, 1H, H-15), 2.15 (s, 3H, SCH3), 2.15 (dd, 1H, J = 13.2, 4.4 Hz, H-18), 2.39 (s, 1H, H-9), 2.44 (m, 1H, SCH2), 2.83 (ddd, 1H, J = 13.2, 2.8, 2.8 Hz, H-1), 3.81 (s, 3H, COOCH3) Isoferulic acid methyl ester 3-(Boc-l-selenomethionine)-11-oxo-olean-12-en-30-oate. found from 21 and N-Boc-l-selenomethionine as a colourless powder. 1.62 (m, 1H, H-6), 1.67 (dd, 1H, J = 13.6, 4.4 Hz, H-19\u2019), 1.77 (m, 1H, H-7), 1.80 (m, 1H, H-2), 1.88 (ddd, 1H, J = 14.8, 14.8, 5.2 Hz, H-16), 1.93 (m, 1H, H-21), 2.13 (dd, 1H, J = 13.2, 4.4 Hz, H-18), 2.39 Isoferulic acid ethyl ester 3-(Boc-l-methionine)-11-oxo-olean-12-en-30-oate. found from 22 and N-Boc-l-methionine as a colourless powder. 1.24 (m, 1H, H-16\u2019), 1.26\u20131.28 (m, 2H, H-22\u2019 and 21\u2019), 1.33 (t, 3H, J = 7.2 Hz, CH3), 1.36 (s, 3H, H-29), 1.40 (s, 3H, H-27), 1.45 (s, 9H, Boc-CH3), 1.48 (m, 1H, H-22), 1.51 (m, 1H, H-7\u2019), 1.58 (m, dd, 1H, J = 8.4, 2.0 Hz, Bn-H-4), 7.60 (d, 1H, Jtrans = 16.0 Hz, H-); 13C-NMR (CDCl3): 200.13, 174.23, 171.83, 169.13, 169.88, 155.04, 152.80, 143.61, 138.08, 128.40, 127.40, 127.38, 121.65, 1H-NMR (CDCl3): 0.80\u20130.83 (m, 1H, H-5), 0.88 (s, 3H, H-28), 0.89 (s, 3H, H-24), 1.05\u20131.09 (m, 1H, H-15\u2019), 1.12\u20131.14 (m, 1H, H-1\u2019), 1.16 (s, 3H, H-26), 1.17 (s, 3H, H-25), 1.20\u20131.24 (m, 1H, H-16 14.0, 3.2, 3.2 Hz, H-1, 3.86 (s, 3H, OCH3), 4.25 (q, 2H, J = 7.2 Hz, CH2CH3), 4.57 (dd, 1H, J = 11.6, 4.8 Hz, H-3), 5.10 (t, 1H, J = 8.4 Hz, CHCOO), 6.30 (d, 1H, J = 16.0 Hz, H-), 6.96 (d, 1H, J trans-3-Hydroxycinnamic acid methyl ester 3-(Boc-l-methionine)-11-oxo-olean-12-en-30-oate. found from 23 and N-Boc-l-methionine as a colourless powder. 6.0 Hz, H-16), 2.07 (m, 1H, H-21), 2.10 (m, 1H, H-15), 2.13 (s, 3H, SCH3), 2.28 (dd, 1H, J = 14.0, 4.8 Hz, H-18), 2.39 (s, 1H, H-9), 2.46 (m, 1H, H-19), 2.57 (m, 2H, SCH2), 2.84 (dd, 1H, J = 10.8, 5.6 trans-3-Hydroxycinnamic acid methyl ester 3-(Boc-l-selenomethionine)-11-oxo-olean-12-en-30-oate. found from 23 and N-Boc-l-selenomethionine as a colourless powder. 1.65 (m, 1H, H-6\u2019), 1.67 (dd, 1H, H-6\u2019), 1.74 (m, 1H, H-2\u2019), 1.77 (m, 1H, H-7), 1.89 (ddd, 1H, H-2), 1.97 (m, 1H, H-21), 2.01 (m, 1H, H-15), 2.02 (s, 3H, SeCH3), 2.16 (dd, 1H, J = 14.0, 4.8 Hz trans-3-Hydroxycinnamic acid ethyl ester 3-(Boc-l-methionine)-11-oxo-olean-12-oate (39) found from 24 and N-Boc-l-methionine as a colourless powder (341 mg, 78%); found from 24 and N-Boc-l-methionine as a colourless powder. s, 3H, H-25), 1.23\u20131.25 (m, 1H, H-16\u2019), 1.26\u20131.28 (m, 2H, H-22\u2019 and 21\u2019), 1.36 (t, 3H, J = 7.2 Hz, CH3), 1.38 (s, 3H, H-29), 1.42 (s, 3H, H-27), 1.47 (s, 9H, Boc-CH3), 1.50 (m, 1H, H-22), 1.53 (m, trans-3-Hydroxycinnamic acid ethyl ester 3-(Boc-l-selenomethionine)-11-oxo-olean-12-en-30-oate (40). Obtained from 24 and N-Boc-l-olean-12-en-30-oate (40). selenomethionine as a colourless powder (364 mg, 79%); 1H-NMR (CDCl3): 0.82\u20130.85 (m, 1H, H-5), 0.90 (s, 3H, H-28), 0.91 (s, 3H, H-24), 1.08\u20131.11 (m, 1H, H-15\u2019), 1.13\u20131.15 (m, 1H, H-1\u2019), 1.17\u20131.15 (m, 1H, H-25), 1. ddd, 1H, J = 13.6, 2.8, 2.8 Hz, H-1, 4.59 (q, 2H, J = 7.2 Hz, CH2CH3), 4.59 (dd, 1H, J = 11.2, 5.2 Hz, H-3), 5.13 (t, 1H, J = 9.2 Hz, CHCOO), 5.71 (s, 1H, H-12), 6.46 (d, 1H, Jtrans = 16.0 Hz, H-), compounds 25\u201340 (0.25 mmol) were dissolved in dry DCM. after saturation with dry hydrogen chloride gas for 10 min, stirring at room temperature was then continued for 24 h. 1H, H-7\u2019), 1.51\u20131.52 (m, 1H, H-6\u2019), 1.53\u20131.55 (m, 1H, H-6\u2019), 1.62 (dd, J = 13.2, 4.0 Hz, 1H, H-19\u2019), 1.67\u20131.69 (m, 1H, H-2\u2019), 1.71\u20131.73 (m, 1H, H-7), 1.75\u20131.78 (m, 1H, H-2), 1.86 (ddd, J = 14.8, 149.96, 145.89, 128.40, 123.15, 118.31, 113.51, 109.11, 81.45, 61.59, 55.69, 54.98, 52.84, 51.69, 48.03, 45.37, 44.50, 43.11, 41.28, 38.10, 38.04, 37.40, 36.86, 32.65, 32.12, 31.83, 31.25, 29. m, 1H, H-16\u2019), 1.21\u20131.24 (m, 2H, H-22\u2019 and 21\u2019), 1.32 (s, 3H, H-29), 1.41 (s, 3H, H-27), 1.43\u20131.45 (m, 1H, H-22), 1.49\u20131.51 (m, 1H, H-7\u2019), 1.52\u20131.53 (m, 1H, H-6\u2019), 1.54\u20131.57 (m, 1H, H-6\u2019), 1.63 13C-NMR (DMSO-d6): 199.92, 174.47, 173.82, 169.27, 166.85, 151.40, 149.94, 145.90, 128.42, 123.02, 121.16, 118.32, 113.49, 109.10, 82.42, 61.54, 55.72, 55.00, 52.81, 51.67, 48.02, 45.34, 0.85 (s, 3H, H-23), 0.90\u20130.93 (m, 1H, H-15\u2019), 1.07 (s, 3H, H-26), 1.08 (s, 3H, H-25), 1.12\u20131.14 (m, 1H, H-16), 1.17\u20131.23 (m, 2H, H-22\u2019 and 21\u2019), 1.27 (t, J = 7.2 Hz, 3H, CH3), 1.31 (s, 3H, H-29), 1. 4.8 Hz, 1H, H-3), 5.46 (s, 1H, H-12), 6.72 (d, Jtrans = 16.0 Hz, 1H, H-), 7.10 (d, J = 8.0, 1.6 Hz, 1H, Bn-H-5), 7.55 (d, J = 16.0 Hz, 1H, Bn-H-3), 7.64 (d, J = 16.0 Hz, 1H, Bn-H-6), 7.64 (d, J onine)-11-oxo-olean-12-en-30-oate hydrochloride (44) Obtained from 28 as a white solid (160 mg, 78%); m.p. 205\u2013207 \u00b0C; 1H-NMR (DMSO-d6): 0.70\u20130.74 (m, 1H, H-5), 0.83 (s, 3H, H-28), 0.84 (s, 3H, H-24), 0.91\u20130.93 (m, 1 43 (s, 1H, H-9), 2.54\u20132.56 (m, 1H, H-19), 2.57\u20132.60 (m, 2H, SeCH2), 2.63 (ddd, J = 13.6, 3.6, 3.6 Hz, 1H, H-1), 3.83 (s, 3H, OCH3), 4.47 (q, J = 7.2 Hz, 2H, CH2CH3), 4.47 (dd, J = 11.6, 4.8 Hz, 1H trans-4-Hydroxycinnamic acid methyl ester 3-(l-methionine)-11-oxo-olean-12-en-30-oate hydrochloride (45) found from 29 as a white solid (143 mg, 76%); found from 29 as a white solid. 87 (ddd, J = 15.2, 15.2, 6.4 Hz, 1H, H-16), 1.93\u20131.95 (m, 1H, H-21), 1.97\u20132.95 (m, 1H, H-15), 2.04 (s, 3H, SCH3), 2.15\u20132.17 (m, 1H, H-18), 2.43 (s, 1H, H-9), 2.53\u20132.55 (m, 1H, H-19), 2.56\u20132.59 (m, 2H methyl ester 3-(l-selenomethionine)-11-oxo-olean-12-en-30-oate hydrochloride (46) found from 30 as a white solid (156 mg, 80%) 1.71\u20131.74 (m, 1H, H-7), 1.78\u20131.81 (m, 1H, H-2), 1.86 (ddd, J = 15.2, 15.2, 6.4 Hz, 1H, H-16), 1.88\u20131.90 (m, 1H, H-21), 1.91\u20131.92 (m, 1H, H-15), 1.93 (s, 3H, SeCH3), 2.15\u20132.18 (m, 1H, H-18), 2.43 (s, 1H 31.93, 31.15, 30.00, 28.59, 28.20, 28.20, 28.18, 26.59, 26.42, 23.65, 23.40, 18.70, 17.29, 16.72, 16.48, 15.53; ESI-MS: m/z = 810.14 [M + H]+. 1H, H-6\u2019), 1.57\u20131.60 (m, 1H, H-6), 1.67\u20131.68 (m, 1H, H-2\u2019), 1.71\u20131.74 (m, 1H, H-7), 1.79\u20131.82 (m, 1H, H-2), 1.87 (ddd, J = 14.8, 14.8, 6.0 Hz, 1H, H-16), 1.93\u20131.95 (m, 1H, H-21), 1.97\u20131.99 (m, 1H, trans-4-Hydroxycinnamic acid ethyl ester 3-(l-selenomethionine)-11-oxo-olean-12-en-30-oate hydrochloride (48) found from 32 as a white solid (145 mg, 73%); found from 32 as a white solid (145 mg, 73%); found from 32 as a white solid (145 mg, 73%); 7.2 Hz, 3H, CH3), 1.33 (s, 3H, H-29), 1.41 (s, 3H, H-27), 1.45\u20131.47 (m, 1H, H-22), 1.49\u20131.51 (m, 1H, H-7\u2019), 1.52\u20131.55 (m, 1H, H-6\u2019), 1.57\u20131.59 (m, 1H, H-6\u2019), 1.65 (dd, J = 13.2, 4.0 Hz, 1H, H m.p. 199\u2013201 \u00b0C; 1H-NMR (DMSO-d6): 0.71\u20130.74 (m, 1H, H-5), 0.84 (s, 3H, H-24), 0.91\u20130.94 (s, 3H, H-15\u2019), 1.00\u20131.03 (m, 1H, H-1\u2019), 1.08 (s, 3H, H-1\u2019), 1.08 (s, 3H, H-1\u2019), 1.08 (s, 3H, H 1.12\u20131.14 (m, 1H, H-16\u2019), 1.20\u20131.24 (m, 2H, H-22\u2019 and 21\u2019), 1.33 (s, 3H, H-29), 1.41 (s, 3H, H-27), 1.46 (m, 1H, H-7\u2019), 1.52 (m, 1H, H-6\u2019), 1.55 (m, 1H, H-6), 1.64 (dd, 1H, J = 13.2, 4.0 Hz, H-19\u2019 13C-NMR (DMSO-d6): 0.71\u20130.74 (m, 1H, H-5), 0.84 (s, 3H, H-28), 0.85 (s, 3H, H-24), 0.91\u20130.94 (m, 1.69; S, 3.97%). found from 34 as a white solid (158 mg, 78%); found: 66.68; H, 8.03; N, 1.69; S, 3.87%. 1.00\u20131.03 (m, 1H, H-1\u2019), 1.08 (s, 3H, H-25), 1.13\u20131.15 (m, 1H, H-16\u2019), 1.20\u20131.24 (m, 2H, H-22\u2019 and 21\u2019), 1.33 (s, 3H, H-29), 1.41 (s, 3H, H-27), 1.46 (m, 1H, H-7\u2019), 1.52 (m, 1H, H-6\u2019), 1.55 (m, 1 dd, 1H, Jtrans = 16.0 Hz, H-); 13C-NMR (DMSO-d6): 200.05, 174.43, 172.75, 169.11, 166.97, 152.85, 143.64, 138.13, 128.43, 127.43, 127.38, 121.70, 116.21, 112.26, 81.42, 61.56, 55.76, 54.91 85 (s, 3H, H-24), 0.85 (s, 3H, H-24), 0.91\u20130.94 (m, 1H, H-15\u2019), 1.08 (s, 3H, H-25), 1.13\u20131.15 (m, 1H, H-16\u2019), 1.18\u20131.21 (m, 2H, H-22\u2019 and 21\u2019), 1.26 (t, 3H, J = 7.2 Hz, CH3), 1.33 (s, 3H, H-29), 1.41 ( 1H, Jtrans = 16.0 Hz, H-), 7.59 (d, 1H, J = 8.4, 2.0 Hz, Bn-H-4), 7.62 (d, 1H, J = 16.0 Hz, H-); 13C-NMR (DMSO-d6): 200.21, 174.46, 172.85, 169.25, 166.90, 152.80, 143.61, 138.08, 128.40, 127. m.p. 196\u2013198 \u00b0C; 1H-NMR (DMSO-d6): 0.71\u20130.75 (m, 1H, H-5), 0.84 (s, 3H, H-28), 0.85 (s, 3H, H-24), 0.91\u20130.93 (m, 1H, H-15\u2019), 1.00\u20131.04 (m, 1H, H-1\u2019), 1.08 (s, 3H, H-25), 1.13\u20131.15 (m, 1H 3.82 (s, 3H, OCH3), 4.47 (q, 2H, J = 7.2 Hz, CH2CH3), 4.47 (dd, 1H, J = 11.6, 4.8 Hz, H-3), 5.48 (s, 1H, H-12), 6.59 (d, 1H, J = 8.4 Hz, Bn-H-3), 7.59 (d, 1H, J = 8.4, 2.0 Hz, Bn-H-4), 7.62 (d, 1 trans-3-Hydroxycinnamic acid methyl ester 3-(l-methionine)-11-oxo-olean-12-en-30-oate hydrochloride (53) Obtained from 37 as a white solid (145 mg, 79%); m.p. 190\u2013192 \u00b0C. m, 1H, H-19, 2.54 (m, 2H, SCH2), 2.63 (ddd, 1H, J = 12.8, 2.8, 2.8 Hz, H-1), 3.74 (s, 3H, COOCH3), 4.47 (dd, 1H, J = 10.8, 5.6 Hz, H-3), 5.48 (s, 1H, H-12), 6.74 (d, 1H, Jtrans = 16.0 Hz, H-), 7.15 ( trans-3-Hydroxycinnamic acid methyl ester 3-(l-selenomethionine)-11-oxo-olean-12-en-30-oate hydro-chloride. found from 38 as a white solid (148 mg, 76%); m.p. 194\u2013196 \u00b0C. 1.93 (s, 3H, SeCH3), 2.18 (m, 1H, H-18), 2.55 (m, 1H, H-9), 2.63 (ddd, 1H, J = 12.8, 2.8, 2.8 Hz, H-1), 3.74 (s, 3H, COOCH3), 4.47 (dd, 1H, J = 10.8, 5.6 Hz, H-3), 5.49 (s, 1H, H-12), 6.74 (d, 1H, J trans-3-Hydroxycinnamic acid ethyl ester 3-(l-methionine)-11-oxo-olean-12-en-30-oate hydrochloride (55) found from 39 as a white solid (136 mg, 73%); m.p. 183\u2013185 \u00b0C; 1H-NMR (DMSO-d6): 0.72\u20130.74 (m, 1H, H-5), 0.84 (s, 3 1.79 (m, 1H, H-2), 1.86 (ddd, 1H, J = 14.8, 14.8, 6.0 Hz, H-16), 1.95 (m, 1H, H-21), 1.98 (m, 1H, H-15), 2.04 (s, 3H, SCH3), 2.19 (m, 1H, H-18), 2.43 (s, 1H, H-9), 2.64 (m, 2H, SCH2), 2.64 (dd, 1H, J trans-3-Hydroxycinnamic acid ethyl ester 3-(l-selenomethionine)-11-oxo-olean-12-en-30-oate hydrochloride (56) found from 40 as a white solid (149 mg, 75%) 1.48 (m, 1H, H-7\u2019), 1.52 (m, 1H, H-6\u2019), 1.57 (m, 1H, H-6), 1.65 (dd, 1H, J = 13.2, 4.0 Hz, H-19\u2019), 1.68 (m, 1H, H-7), 1.76 (m, 1H, H-2), 1.86 (ddd, 1H, J = 14.8, 14.8, 6.0 Hz, H-16), 1.89 (m, 1H, H-21 anticancer assays based on the conversion of MTT to formazan crystals by mitochondrial dehydrogenases. the three lines of cells (MCF-7, MDA-MB-231 and hTERT-RPE1) were cultured in 96 well plates for 24 h with a density of 0.8 104 cells/well. glycyrrhetinic acid derivates were designed, synthesized and evaluated for their inhibitory activities. most of the prepared compounds displayed moderate cytotoxic activity against both cancer cell lines and relatively lower inhibitory activity against the normal cell line. compound 42 exhibited good antiproliferative activity, with IC50 values of 1.88 0.20 and 1.37 0.18 M."}